Impact of Plasma p‐tau181 on Cognition, Motor Phenotypes, and Disease Course in ALS
ABSTRACT Phosphorylated tau181 (p‐tau181), an Alzheimer's disease biomarker, was recently evaluated in amyotrophic lateral sclerosis (ALS). We investigated plasma p‐tau181 in 202 ALS/ALS‐FTD patients and 94 healthy controls, assessing cognitive performance, motor function, and longitudinal dynamics.
Elisabeth Kasper +25 more
wiley +1 more source
Chinese capillary malformation-arteriovenous malformation: clinical and genetic analysis of eight cases. [PDF]
Lin Y +5 more
europepmc +1 more source
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source
Rectal Prolapse as a Rare Presentation of Colorectal Cancer: Case Series and Clinical Perspectives. [PDF]
Nugraha P +4 more
europepmc +1 more source
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick +6 more
wiley +1 more source
Not all cervical masses are ganglions. A case series of 24 patients presenting benign brachial plexus tumors with emphasis on 5 biopsied patients and review of literature. [PDF]
Dubuisson A, Tamburrini T, Steinmetz M.
europepmc +1 more source
Analysis of factors influencing retinal thickness in chronic obstructive pulmonary disease and hypertension: a cross-sectional study in a community-dwelling middle-aged and elderly population. [PDF]
Yu D +10 more
europepmc +1 more source
Age-Related Differences in Efficacy and Safety of Subcutaneous Immunotherapy in Allergic Rhinitis: A Real-World Study. [PDF]
Jia J +9 more
europepmc +1 more source

